Harvard Apparatus Regenerative Technology, Inc. (HRGN) Return on equity 2016–2025
Harvard Apparatus Regenerative Technology, Inc. (HRGN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-649.9%FY2025 · since FY2016: -652.7% → -649.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -649.9% | -409.9 pp |
| FY2024 | -240.0% | +303.5 pp |
| FY2023 | -543.4% | — |
| FY2020 | -432.4% | +332.7 pp |
| FY2019 | -765.1% | -383.1 pp |
| FY2018 | -382.0% | -33.9 pp |
| FY2017 | -348.1% | +304.6 pp |
| FY2016 | -652.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More HRGN financial trends
HRGN RevenueHRGN Net incomeHRGN Net marginHRGN Gross profitHRGN Gross marginHRGN Operating incomeHRGN Operating marginHRGN Operating cash flowHRGN Free cash flowHRGN Capital expendituresHRGN Stock buybacksHRGN Dividends paidHRGN Total assetsHRGN Total liabilitiesHRGN Shareholders’ equityHRGN overview →